Newsroom

Sorted by: Latest

-

Atom Therapeutics Launches Multi-Regional Phase 2 Trial of ABP-745 for Atherosclerotic Cardiovascular Disease (ASCVD)

HANGZHOU, China--(BUSINESS WIRE)--Atom now has a strategic foothold in dual therapeutic areas of metabolism and cardiovascular diseases, strengthening its core competitive edge....
-

Waitrose Partners with GLORY to Transform Back Office Cash Management Processes

BASINGSTOKE, England--(BUSINESS WIRE)--Glory (TYO: 6457), a global and UK leader in cash automation solutions has announced that supermarket Waitrose has selected the company’s CI-100X solution to streamline and improve their back office cash management process in its stores across the UK. Glory is installing two hundred and eighty five CI-100X back office cash recycling devices in Waitrose stores with the rollout already underway. Glory's CI-100X solution offers enhanced flexibility, capabilit...
-

Hexnode als führendes Unternehmen in IDC MarketScape ausgezeichnet: Weltweite UEM-Software für Apple-Geräte 2025/26 – Anbieterbewertung

MUNICH--(BUSINESS WIRE)--Hexnode UEM, die Unternehmenssoftwaresparte von Mitsogo Inc., gibt bekannt, dass sie in fünf Berichten von IDC MarketScape: Worldwide Unified Endpoint Management Software Vendor Assessment aufgeführt ist. Die Auflistung enthält eine Bewertung der wichtigsten Anbieter auf dem Markt für Unified Endpoint Management. Hexnode als führendes Unternehmen ausgezeichnet, in „:IDC MarketScape: Worldwide Unified Endpoint Management Software for Apple Devices 2025/26 Vendor Assessme...
-

Lightspeed clôture plus de 9 milliards USD de nouveaux fonds destinés à soutenir les entreprises qui redéfinissent leur secteur d’activité à travers le monde

MENLO PARK, Californie--(BUSINESS WIRE)--Lightspeed Venture Partners (« Lightspeed ») a annoncé aujourd’hui la clôture d’un capital engagé de plus de 9 milliards USD répartis entre six véhicules distincts et hautement sélectifs, à savoir Lightspeed Venture Partners Fund XV-A (980 millions USD), Lightspeed Venture Partners Fund XV-B (1,2 milliard USD), Lightspeed Select VI (1,8 milliard USD) et Lightspeed Opportunity Fund III (3,3 milliards USD), ainsi que Lightspeed Co-Investment Fund I (600 mi...
-

Long Pond Capital, LP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Long Pond Capital, LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  ...
-

Nucleus Software’s FinnOne Neo® Platform Has Provided an Innovative Solution for MBBank’s Management Ecosystem.

HANOI, Vietnam--(BUSINESS WIRE)--Nucleus Software’s FinnOne Neo® platform has provided an innovative solution for Military Joint Stock Commercial Bank’s management ecosystem....
-

Hummingbird Diagnostics Publishes Study on RNA Biomarker Methylation in Liquid Biopsies

HEIDELBERG, Germany--(BUSINESS WIRE)--Hummingbird Diagnostics GmbH, a pioneer in harnessing blood-based small RNAs for early disease detection and characterization, today announced the publication of a new study in Nature Communications Medicine introducing an Oxford Nanopore Technologies (ONT)-based method for detecting small RNA modifications in blood. The research demonstrates that direct small RNA sequencing can identify differential RNA methylation patterns associated with lung cancer, rep...
-

Hummingbird Diagnostics veröffentlicht Studie zur RNA-Biomarker-Methylierung in Liquid Biopsies

HEIDELBERG, Deutschland--(BUSINESS WIRE)--Die Hummingbird Diagnostics GmbH, ein Vorreiter im Bereich blutbasierter small RNAs zur Krankheitsfrüherkennung und Charakterisierung, hat eine Studie in Nature Communications Medicine veröffentlicht. Die Arbeit beschreibt eine auf der Oxford Nanopore Technologie (ONT) basierende Methode zum Nachweis von small RNA-Modifikationen im Blut. Hummingbirds Forschung belegt, dass sich mit direkter small RNA-Sequenzierung Unterschiede in der RNA-Methylierung na...
-

TimesSquare Capital Management, LLC UK Regulatory Announcement: Form 8.3

NEW YORK--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: TimesSquare Capital Management, LLC (“TimesSquare”) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor an...
-

AIG Appoints Adam Clifford, Chief Executive Officer, International Commercial Insurance

NEW YORK--(BUSINESS WIRE)--AIG Appoints Adam Clifford, Chief Executive Officer, International Commercial Insurance...